| Name | 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide |
|---|---|
| Synonyms |
4-Thiazolecboxamide, 2-β-D-ribofuranosyl
(1R)-1,4-Anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-D-ribitol Riboxamide 2-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)thiazole-4-cboxamide 2-β-D-Ribofuranosyl-4-thiazolecarboxamide [3H]-Tiazofurin NSC-286193 Tiazole 2-β-D-Ribofuranosyl-4-thiazolecboxaMide 2-b-D-Ribofuranosyl-4-thiazolecboxaMide Tiazofurinum [Latin] tiazofurin Aids-014479 2-β-D-Ribofuranosylthiazole-4-cboxaMide Tiazofurin, 10 mM in DMSO 2-b-D-Ribofuranosyl-4-thiazolecarboxamide Tiazofurina [Spanish] NSC-286-193 Tiazofurine Tiazofurina Aids014479 2-.beta.-D-Ribofuranosyl-4-thiazolecboxamide Tiazofurinum 2-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-cboxamide 2-β-D-Ribofuranosylthiazole-4-carboxamide Nucleoside Antimetabolite/Analog,NSC-286193,Inhibitor,Tiazofurin,inhibit,NSC286193,Orthopoxvirus |
| Description | Tiazofurin is a synthetic nucleoside analogue with antineoplastic activity. Tiazofurin is anabolized intracellularly to tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH). |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 641.3±55.0 °C at 760 mmHg |
| Molecular Formula | C9H12N2O5S |
| Molecular Weight | 260.267 |
| Flash Point | 341.6±31.5 °C |
| Exact Mass | 260.046692 |
| PSA | 154.14000 |
| LogP | -1.13 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.675 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934100090 |
| Precursor 5 | |
|---|---|
| DownStream 3 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |